RPG Life Sciences Share Price

RPG Life Sciences Limited is an India-based research-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations, and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has a presence in nephrology, oncology, rheumatology, cardiology, respiratory, pain management, vitamins & minerals, gastroenterology, and gynecology & pediatrics. The International Formulations business operates in the generics and branded generics space across Canada, Europe, Australia, New Zealand, and South America. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Quinfamide, Nicorandil, Haloperidol, Risperidone, Tolvaptan, Spironolactone, Sertraline, Naprosyn, Teristrong, and others.As of 16 Jun 2026, RPG Life Sciences share price is ₹2,277.00. The stock opened at ₹2,286.20, compared to its previous close of ₹2,297.70. During today's trading session, RPG Life Sciences share price moved in the range of ₹2,262.70 to ₹2,321.90, with an average price of ₹2,292.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,262.70 and a high of ₹2,321.90. On the performance front, RPG Life Sciences share price has declined by 1.42% over the last six months and is down 4.61% on a year-on-year basis.

The market capitalization of RPG Life Sciences is ₹3,803 Crs, with a P/E ratio of 33.0 and a dividend yield of 1.04%.